Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| BRSL | BRIGHTSTAR LOTTERY | $3.34B | 201,858,765 | 49.75% | 0.00% | ||||
| HOWL | WEREWOLF THERAPEUTICS INC | $68.14M | 45,728,999 | 42.70% | 57.30% | Net Buying | |||
| CHA | CHAGEE HOLDINGS LTD | $3.19B | 183,549,892 | 5.62% | 0.00% | ||||
| MVIS | MICROVISION INC | $321.55M | 249,261,553 | 33.57% | 11.83% | Net Selling | Net Selling | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $7.78B | 60,658,809 | 28.83% | 71.17% | Net Selling | Net Selling | ||
| AIOT | POWERFLEET INC | $712.59M | 133,443,292 | 78.56% | 21.44% | Net Selling | Net Buying | ||
| DNUT | KRISPY KREME INC | $581.40M | 170,000,000 | 15.92% | 84.08% | Net Selling | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $257.38M | 221,881,029 | 70.14% | 29.86% | Net Selling | |||
| CCI | CROWN CASTLE INC | $40.76B | 435,470,061 | 76.04% | 23.96% | Net Selling | Net Selling | ||
| CZR | CAESARS ENTERTAINMENT INC | $5.32B | 207,991,539 | 77.83% | 22.17% | Net Selling | |||
| ADTN | ADTRAN HOLDINGS INC | $760.50M | 80,052,167 | 73.44% | 26.56% | Net Selling | Net Selling | ||
| GDS | GDS HOLDINGS LTD | $7.57B | 1,555,180,903 | 5.21% | 0.00% | ||||
| SION | SIONNA THERAPEUTICS INC | $1.02B | 44,139,823 | 63.96% | 36.04% | Net Buying | Net Selling | ||
| ICHR | ICHOR HOLDINGS LTD | $633.00M | 34,327,355 | 68.94% | 31.06% | Net Buying | Net Buying | ||
| ESTC | ELASTIC NV | $9.48B | 106,270,940 | 57.80% | 42.20% | Net Selling | Net Selling | ||
| FLD | FOLD HOLDINGS INC | $211.96M | 46,789,930 | 4.07% | 74.59% | Net Buying | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $86.83M | 89,704,194 | 76.50% | 1.46% | Net Buying | |||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $21.05B | 1,147,150,917 | 62.80% | 0.79% | Net Selling | Net Selling | ||
| SI | SHOULDER INNOVATIONS INC | $293.59M | 20,359,960 | 0.00% | 58.21% | Net Buying | Net Buying | ||
| NRIX | NURIX THERAPEUTICS INC | $645.23M | 76,449,355 | 91.26% | 8.74% | Net Selling | Net Selling | ||
| TSHA | TAYSHA GENE THERAPIES INC | $772.01M | 272,794,885 | 89.44% | 10.56% | Net Buying | Net Selling | ||
| ALMS | ALUMIS INC | $433.95M | 104,064,302 | 75.27% | 24.28% | Net Buying | |||
| UTI | UNIVERSAL TECHNICAL INSTITUTE INC | $1.54B | 54,406,215 | 70.16% | 29.84% | Net Selling | Net Buying | ||
| DNLI | DENALI THERAPEUTICS INC | $1.86B | 146,212,278 | 60.84% | 39.16% | Net Selling | Net Buying | ||
| CARL | CARLSMED INC | $376.12M | 26,581,134 | 0.00% | 54.33% | Net Buying | Net Buying | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.12B | 59,235,547 | 49.48% | 50.52% | Net Selling | Net Selling | ||
| RAPP | RAPPORT THERAPEUTICS INC | $962.09M | 36,497,920 | 70.41% | 29.59% | Net Selling | Net Selling | ||
| KAPA | KAIROS PHARMA LTD | $25.31M | 20,743,765 | 1.05% | 32.68% | Net Buying | |||
| ENGN | ENGENE HOLDINGS INC | $337.92M | 51,191,771 | 68.02% | 31.98% | Net Buying | |||
| CSTL | CASTLE BIOSCIENCES INC | $708.09M | 29,008,281 | 85.56% | 14.44% | Net Selling | Net Selling | ||
| NKTX | NKARTA INC | $142.05M | 71,024,512 | 62.30% | 37.70% | Net Selling | |||
| COGT | COGENT BIOSCIENCES INC | $1.67B | 139,700,796 | 89.41% | 10.59% | Net Buying | Net Buying | ||
| TYRA | TYRA BIOSCIENCES INC | $666.21M | 53,297,140 | 62.08% | 37.92% | Net Buying | Net Buying | ||
| TARA | PROTARA THERAPEUTICS INC | $123.08M | 38,581,863 | 48.28% | 51.72% | Net Buying | |||
| SMLR | SEMLER SCIENTIFIC INC | $432.00M | 14,804,693 | 62.05% | 37.95% | Net Buying | Net Buying | ||
| CBIO | CRESCENT BIOPHARMA INC | $179.49M | 13,892,562 | 13.05% | 86.95% | ||||
| TECX | TECTONIC THERAPEUTIC INC | $280.31M | 18,712,128 | 23.90% | 76.10% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.